RB and cell cycle progression

被引:0
|
作者
C Giacinti
A Giordano
机构
[1] Sbarro Institute for Cancer Research and Molecular Medicine,Department of Human Pathology and Oncology
[2] Temple University,undefined
[3] University of Siena,undefined
来源
Oncogene | 2006年 / 25卷
关键词
Rb; cell cycle; E2F; cancer; Rb2/p130; tumor suppressor;
D O I
暂无
中图分类号
学科分类号
摘要
The Rb protein is a tumor suppressor, which plays a pivotal role in the negative control of the cell cycle and in tumor progression. It has been shown that Rb protein (pRb) is responsible for a major G1 checkpoint, blocking S-phase entry and cell growth. The retinoblastoma family includes three members, Rb/p105, p107 and Rb2/p130, collectively referred to as ‘pocket proteins’. The pRb protein represses gene transcription, required for transition from G1 to S phase, by directly binding to the transactivation domain of E2F and by binding to the promoter of these genes as a complex with E2F. pRb represses transcription also by remodeling chromatin structure through interaction with proteins such as hBRM, BRG1, HDAC1 and SUV39H1, which are involved in nucleosome remodeling, histone acetylation/deacetylation and methylation, respectively. Loss of pRb functions may induce cell cycle deregulation and so lead to a malignant phenotype. Gene inactivation of pRB through chromosomal mutations is one of the principal reasons for retinoblastoma tumor development. Functional inactivation of pRb by viral oncoprotein binding is also shown in many neoplasias such as cervical cancer, mesothelioma and AIDS-related Burkitt's lymphoma.
引用
收藏
页码:5220 / 5227
页数:7
相关论文
共 50 条
  • [1] RB and cell cycle progression
    Giacinti, C.
    Giordano, A.
    ONCOGENE, 2006, 25 (38) : 5220 - 5227
  • [2] Using kinetic studies to uncover new Rb functions in inhibiting cell cycle progression
    Ji, P
    Zhu, L
    CELL CYCLE, 2005, 4 (03) : 373 - 375
  • [3] Effects of farnesyl transferase inhibitors on cell cycle progression, cyclin expression and Rb phosphorylation
    Mayer-Ezell, R
    Ramos, RA
    Kirschmeier, R
    Pai, JK
    Pachter, JA
    FASEB JOURNAL, 1997, 11 (09): : A1088 - A1088
  • [4] Cell cycle progression
    Tyrcha, J
    COMPTES RENDUS BIOLOGIES, 2004, 327 (03) : 193 - 200
  • [5] Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
    Hernando, E
    Nahlé, Z
    Juan, G
    Diaz-Rodriguez, E
    Alaminos, M
    Hemann, M
    Michel, L
    Mittal, V
    Gerald, W
    Benezra, R
    Lowe, SW
    Cordon-Cardo, C
    NATURE, 2004, 430 (7001) : 797 - 802
  • [6] Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
    Eva Hernando
    Zaher Nahlé
    Gloria Juan
    Elena Diaz-Rodriguez
    Miguel Alaminos
    Michael Hemann
    Loren Michel
    Vivek Mittal
    William Gerald
    Robert Benezra
    Scott W. Lowe
    Carlos Cordon-Cardo
    Nature, 2004, 430 : 797 - 802
  • [7] Rb interactome data and its modulations during cell cycle progression in HEK 293 cells
    Duggal, Shweta
    Jailkhani, Noor
    Midha, Mukul Kumar
    Rao, Kanury V. S.
    Kumar, Ajay
    DATA IN BRIEF, 2018, 17 : 604 - 609
  • [8] RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells
    Kontani, K
    Chano, T
    Ozaki, Y
    Tezuka, N
    Sawai, S
    Fujino, S
    Saeki, Y
    Okabe, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (05) : 767 - 769
  • [9] RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
    Cho, Hyun-Soo
    Hayami, Shinya
    Toyokawa, Gouji
    Maejima, Kazuhiro
    Yamane, Yuka
    Suzuki, Takehiro
    Dohmae, Naoshi
    Kogure, Masaharu
    Kang, Daechun
    Neal, David E.
    Ponder, Bruce A. J.
    Yamaue, Hiroki
    Nakamura, Yusuke
    Hamamoto, Ryuji
    NEOPLASIA, 2012, 14 (06): : 476 - +
  • [10] Mesalazine and cell cycle progression
    Luciani, M. G.
    Gasche, C.
    INTESTINAL INFLAMMATION AND COLORECTAL CANCER, 2007, 158 : 236 - 243